Itamar Launches Cardiovascular Health Assessment Platform at ACC

 

March 26, 2012

Itamar-Medical released its cardiovascular healthcare assessment platform, EndoPAT-MF, at the American College of Cardiology’s 2012 Annual Scientific Session. The multifunction EndoPAT-MF now features five major diagnostic tools in a single system. In addition to providing the only U.S. Food and Drug Administration (FDA)-cleared, non-invasive measure of endothelial function, the platform also features an augmentation index measuring arterial stiffness and heart rate variability (offering a window onto the autonomic nervous system), as well as leading risk score calculators (Framingham, Reynolds and SCORE) and an integrated Web-based platform, EndoCloud, to provide seamless and efficient patient diagnosis information transfer in a timely manner.

The EndoPAT-MF will be available upon meeting the regulatory requirements in each of the international geographies. The integrated platform will enable all users to benefit from convenience and cost savings by performing the diagnostic tasks of several devices on a single, unified platform.

For more information: www.itamar-medical.com